Jesse I. Treu

Jesse I. Treu is a declared insider at 24 companies; the most frequent names are Orexigen Therapeutics, Inc., Volcano Corp and Somaxon Pharmaceuticals, Inc. The record holds 275 filings, for trades running from 6 February 2006 to 26 March 2019.

On the open market, the record shows 64 purchases worth €84.0M and 61 sales worth €76.3M. Taken together, the purchases exceed the sales by €7.6M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 14 share grants. In 2019 alone, the filings show no purchases and 10 sales.

The median purchase comes to €173k.

Most recently, on 28 March 2019, the filings show an open-market sale worth €3,936 in Aldeyra Therapeutics, Inc. The most recent open-market purchase was published on 28 August 2013, 4,804 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.